Breast Health

Latest News

Exogenous hormone use not associated with increased breast cancer risk: © NaMong Productions - stock.adobe.com
Exogenous hormone use not associated with increased breast cancer risk

September 29th 2023

Benefits of exogenous hormone use, as well as data indicating no association with increased breast cancer risk, were discussed at The Menopause Society 2023 Annual Meeting.

Study reveals drivers of breast cancer awareness and mammography compliance
Study reveals drivers of breast cancer awareness and mammography compliance

June 28th 2022

Breast cancer imaging
Same mutations linked to breast cancer risk found in black, white women

November 8th 2021

New study shows racial disparities in genetic testing referrals for women
New study shows racial disparities in genetic testing referrals for women

November 5th 2021

Shortness of breath. Unhappy mature woman sweating and touching head
Aromatase inhibitors for climacteric symptoms in women with breast cancer

July 8th 2020

Latest CME Events & Activities

23rd Annual International Congress on the Future of Breast Cancer® East

Register Now!

Reflective Case-Based Oncology Collective: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

5th Annual Precision Medicine Symposium: An Illustrated Tumor Board

Register Now!

7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

Register Now!

Expanding Options Beyond Conventional Therapy in HR+ Breast Cancer to Overcome Unmet Needs

View More

21st Annual School of Breast Oncology

Register Now!

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow®

Register Now!

Clinical Conversations With the Cancer Care Team: Discussing the Impact of Social Inequities on Treatment Outcomes in Triple-Negative Breast Cancer

View More

Community Practice Connections™: Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers

View More

Burst CME™ - Part III – Advent of HER3 Targeted Approaches and Rationale in Breast Cancer Care

View More

Burst CME™ - Part I – Overview of Pathophysiology, Diagnosis, and Management of HER3 Expressing Cancers

View More

Burst CME™ - Part II – Advent of HER3 Targeted Approaches and Rationale in NSCLC Care

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Advances In™: Meeting Unmet Clinical Needs in TNBC and HR+ Breast Cancer with TROP2-Targeted Regimens

View More

Medical Crossfire®: Clinical Decision-Making Under New Paradigms for HR+/HER2- Breast Cancer

View More

Oncology Consultations®: Clinical Impact of HER2-Low Expressing Breast Cancer and Novel Targeted Therapies to Address Unmet Needs in Care

View More

Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow

View More

BURST CME™: Addressing Current Standards and Unmet Needs in Patients with Metastatic Breast Cancer

View More

School of Breast Oncology® Live Video Webcast: Clinical Updates From San Antonio

View More

Community Practice Connections™: 6th Annual Precision Medicine Through Plasma™ – Using Liquid Biopsies in Contemporary Oncology Care

View More

Clinical Vignettes: 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

View More

Community Practice Connections™: Clinical Decision Making Under New Paradigms for HR+/HER2-Breast Cancer

View More

School of Breast Oncology

View More

41st Annual Miami Breast Cancer Conference®

Register Now!

Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple Sclerosis – Understanding Patient Challenges and the Role of Innovative Treatment

View More

Optimizing Pain Management for Breast Cancer Surgery Patients in the Age of the Opioid Epidemic

View More

Identifying and Mitigating Disparities in Breast Cancer Care: Improving Diagnostics, Trial Access and Care for All Patients

View More

Medical Crossfire®: Optimizing Treatment Sequencing for HR+/HER2- Metastatic Breast Cancer Based on Emerging Evidence and Evolving Algorithms

View More

Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis

View More

Community Practice Connections™: What’s Next for Patients with Breast Cancer, and How Can We Effectively Optimize PARP-, HER2/3-, and TROP2-Targeted Regimens in Treatment Plans?

View More

More News

© 2023 MJH Life Sciences

All rights reserved.